Michael Detmar
Impact in
- Oncology top 0.02%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Dermatology top 0.05%
Papers in
- Oncology 188
- Lymphatic System and Diseases 163
- Cancer Cells and Metastasis 19
-
- Angiogenesis and VEGF in Cancer 99
- Co-authors
- Lawrence F. Brown (26 shared papers)Harold F. Dvorak (10 shared papers)Ann M. Dvořàk (4 shared papers)Steven T. Proulx (49 shared papers)Sinem Karaman (24 shared papers)Kari Alitalo (13 shared papers)Satoshi Hirakawa (18 shared papers)Kevin P. Claffey (10 shared papers)
- Journals
- Journal of Investigative Dermatology (35 papers)American Journal Of Pathology (20 papers)Blood (14 papers)PLoS ONE (8 papers)Cancer Research (8 papers)
- Partner nations
- SwitzerlandUnited StatesGermany
In The Last Decade
Michael Detmar
294 papers receiving 33.1k citations
Michael Detmar's Hit Papers
Peers
Comparison fields: 5 of 175
- Oncology 14.1k
- Dermatology 2.9k
- Immunology and Allergy 1.8k
- Cancer Research 3.8k
- Immunology 4.2k
Countries citing papers authored by Michael Detmar
This map shows the geographic impact of Michael Detmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Detmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Detmar more than expected).
Fields of papers citing papers by Michael Detmar
This network shows the impact of papers produced by Michael Detmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Detmar. The network helps show where Michael Detmar may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Detmar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 298 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Hit paper breakdown → | 1995 | 2610 |
| 2 | A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules Hit paper breakdown → | 2015 | 1584 |
| 3 | Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis Hit paper breakdown → | 2001 | 1430 |
| 4 | Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis Hit paper breakdown → | 2008 | 719 |
| 5 | Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea Hit paper breakdown → | 2002 | 616 |
| 6 | VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis Hit paper breakdown → | 2005 | 578 |
| 7 | Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. Hit paper breakdown → | 1994 | 576 |
| 8 | T1α/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema Hit paper breakdown → | 2003 | 541 |
| 9 | Control of hair growth and follicle size by VEGF-mediated angiogenesis Hit paper breakdown → | 2001 | 537 |
| 10 | TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays Hit paper breakdown → | 2009 | 535 |
| 11 | Outflow of cerebrospinal fluid is predominantly through lymphatic vessels and is reduced in aged mice Hit paper breakdown → | 2017 | 509 |
| 12 | Up-Regulation of the Lymphatic Marker Podoplanin, a Mucin-Type Transmembrane Glycoprotein, in Human Squamous Cell Carcinomas and Germ Cell Tumors Hit paper breakdown → | 2005 | 508 |
| 13 | Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. | 1996 | 492 |
| 14 | 1998 | 456 | |
| 15 | 2002 | 436 | |
| 16 | 2002 | 428 | |
| 17 | Mechanisms of lymphatic metastasis Hit paper breakdown → | 2014 | 426 |
| 18 | 2006 | 412 | |
| 19 | 1997 | 404 | |
| 20 | 1997 | 403 |
About Michael Detmar
Michael Detmar is a scholar working on Oncology, Molecular Biology, Surgery, Dermatology and Physiology, having authored 298 papers that have together received 33.8k indexed citations. Recurring topics across this work include Lymphatic System and Diseases (163 papers), Angiogenesis and VEGF in Cancer (99 papers), Sympathectomy and Hyperhidrosis Treatments (39 papers), Dermatologic Treatments and Research (21 papers), Lymphatic Disorders and Treatments (20 papers), Cancer Cells and Metastasis (19 papers), Vascular Malformations and Hemangiomas (19 papers) and Cell Adhesion Molecules Research (16 papers). The work is most often cited by research in Oncology (14.1k citations), Dermatology (2.9k citations), Immunology and Allergy (1.8k citations), Cancer Research (3.8k citations) and Immunology (4.2k citations). Michael Detmar has collaborated with scholars based in Switzerland, United States and Germany. Frequent co-authors include Lawrence F. Brown, Harold F. Dvorak, Ann M. Dvořàk, Steven T. Proulx, Sinem Karaman, Kari Alitalo, Satoshi Hirakawa, Kevin P. Claffey, Paula Velasco and Young‐Kwon Hong. Their work appears in journals such as Journal of Investigative Dermatology, American Journal Of Pathology, Blood, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.